CEimpact Podcast (CEimpact)
Explorez tous les épisodes de CEimpact Podcast
| Date | Titre | Durée | |
|---|---|---|---|
| 29 Dec 2020 | Right in Two | GameChangers | 00:29:06 | |
The efficacy of antiretroviral therapy has led to persons with HIV living a near-normal lifespan. But medications only work when used appropriately. The International Antiviral Society-USA Panel published updated recommendations for the treatment and prevention of HIV infections. Treatment of HIV may be distilled into a simple idea - two "nucs" and something else. Learn how to optimize care for your patients.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-1669. Available at: https://www.iasusa.org/2020/11/12/antiretroviral-drugs-treatment-prevention-hiv-infection-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel/ The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. | |||
| 09 Mar 2021 | Lost in the Weeds | GameChangers | 00:23:16 | |
The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf CPE details for GameChangers Podcast March 2021Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 27 Oct 2020 | The 3,000 Year Old Miracle Drug | GameChangers | 00:24:02 | |
The LoDoCo2 Trial suggested that colchicine may improve outcomes in patients with cardiovascular disease. Can a 3,000 year old drug still be a miracle?Additional Resources/References: Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020 Aug 31. doi: 10.1056/NEJMoa2021372. Epub ahead of print. PMID: 32865380.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information. | |||
| 22 Sep 2020 | This is Me Trying | GameChangers | 00:23:30 | |
The TAILOR-PCI Trial evaluates the outcomes between genotype-guided P2Y12 inhibitor selection versus conventional prescribing on ischemic outcomes. Listen to Geoff Wall and guest, Jake Galdo, discuss the role of pharmacogenomics in patient care.Additional Resource/Reference:https://jamanetwork.com/journals/jama/article-abstract/2769725 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information. | |||
| 29 May 2020 | Evidence for SGLT2 Drugs for Heart Failure in Patients without Diabetes | GameChangers | 00:26:00 | |
Geoff Wall, PharmD & Jamie Pitlick, PharmD discussing SGLT2 inhibitors, also called gliflozins, are a class of medications that inhibit reabsorption of glucose in the kidney and therefore lower blood sugar. Recently SGLTs, which are currently indicated for Type 2 diabetes, have been investigated and received FDA approval for Heart failure with reduced ejection fraction (HFrEF). Listen in to this episode to discover more about how these drugs work in this (HFrEF) disease state.This episode is accredited for CPE. This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2ApMvWw See omnystudio.com/listener for privacy information. | |||
| 01 Dec 2020 | I've Got You Under My Skin | GameChangers | 00:25:04 | |
Atopic Dermatitis is not extensively taught in pharmacy curriculum. With several international medical societies publishing updated guidelines and newly approved medications, it's time for a review. Clinicians can learn ways to help treat patients under the skin.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. | |||
| 20 Apr 2021 | You Never Give Me Your Money | GameChangers | 00:36:05 | |
Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money.Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195CPE details for GameChangers Podcast April 2021Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association.See omnystudio.com/listener for privacy information. | |||
| 31 Jul 2020 | Rational Use of Skeletal Muscle Relaxants | GameChangers | 00:27:00 | |
Geoff Wall, PharmD delivers another great podcast. Pharmacists see skeletal muscle relaxant prescriptions daily but how much real experience do we have with these drugs? Do they work? Are they safe? This episode covers what should every pharmacist know about these medications.This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2CEy161 See omnystudio.com/listener for privacy information. | |||
| 08 Sep 2020 | Who Ya Gonna Call? | GameChangers | 00:24:04 | |
Community Pharmacies are vital members of neighborhoods and the healthcare community. A major social determinant of health is access to healthcare - both providers and medications. Recently, Berenbrok and colleagues published research that showed community pharmacies are visited almost twice as much compared to primary care providers by Medicare beneficiaries annually. Guest Jake Galdo will be joining our host Geoff Wall to discuss how community pharmacists provide care.Additional Resource/Reference: https://jamanetwork.com/journals/jamanetworkopen/fullarUcle/2768247 This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!See omnystudio.com/listener for privacy information. | |||
| 21 Aug 2020 | Management of Diabetic Ketoacidosis: Focus on the Gap | GameChangers | 00:24:22 | |
A recent study suggests that SGLT2 drugs - now shown to dramatically improve cardiovascular and renal outcomes in a wide variety of patients - have a higher incidence of euglycemic DKA than previously thought. If pharmacists see more of this ADR, how do we treat appropriately - especially when a patient's sugars may not be very high?This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3gy7F4O See omnystudio.com/listener for privacy information. | |||
| 14 Aug 2020 | Adverse Effects of Corticosteroids in Both Short and Long Term Treatment Periods | GameChangers | 00:24:00 | |
Most prescribers believe that short course of steroids have no serious adverse effects, but a recent study from the Annals of Internal Medicine challenges that notion. What does the pharmacist need to know about the short and long term adverse effects of steroids and how to proactively prevent them?Additional Resources/ReferencesAssociation between Oral Corticosteroid Bursts and Severe Adverse Events: https://www.acpjournals.org/doi/pdf/10.7326/M20-0432 This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2XxYr0T See omnystudio.com/listener for privacy information. | |||
| 16 Mar 2021 | Lose Yourself | GameChangers | 00:24:32 | |
The recently published STEP trial showed a dramatic effect on weight loss with the weekly injectable semaglutide versus placebo. Lay media picked up the headlines from this potential "GameChanger" medication for weight loss. With this one shot will patient lose themselves?Reference: Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. February 10, 2021. DOI: 10.1056/NEJMoa2032183CPE details for GameChangers Podcast March 2021Learning Objective: Discuss the design of the STEP trial0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 17 Nov 2020 | Home Sweet Home (It's Where the Heart Is) | GameChangers | 00:26:36 | |
Sodium Glucose Co-Transporter-2 Inhibitors, a medication class for the treatment of diabetes, is now showing benefits in other medical conditions, like heart failure and kidney disease. Is this a class effect?Additional Resources/References: McGuire DK, Shih WJ, Cosentino F, et al. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: A Meta-analysis . JAMA Cardiol. Published online October 07, 2020. doi:10.1001/jamacardio.2020.4511This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! See omnystudio.com/listener for privacy information. | |||
| 17 Jul 2020 | COVID Infections and the Latinx Patient: Perspectives from the Front Lines | GameChangers | 00:26:20 | |
The COVID-19 pandemic has disproportionally affected Latinx Americans. Learn how pharmacists can optimize patient care for Latinx patients by discussing how to overcome economic and language barriers. In this episode, we'll talk with Dr. Sally Haack who cares for Latinx patients on a daily basis in her pharmacy practice.Special guest: Sally Haack, PharmD, BCPS Associate Professor Drake UniversityThis episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2YogiIp See omnystudio.com/listener for privacy information. | |||
| 23 Feb 2021 | Where There's Smoke, There's Fire | GameChangers | 00:22:12 | |
The United States Preventative Services Task Force (USPSTF) recommendations for tobacco cessation have been recently updated. While no major changes to pharmacotherapy recommendations are in the new guidelines, the paper does emphasize that all health care providers can work with patients to help them achieve tobacco freedom. Learn how to support patients in your community.Reference: USPSTF Recommendation: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions CPE details for GameChangers Podcast February 2021Learning Objective: Discuss the rates of tobacco cessation and adverse effects of current Food and Drug Administration approved therapy for tobacco cessation.0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 02 Mar 2021 | Bears. Beets. COVID-19 Updates | GameChangers | 00:21:40 | |
The recently published (in a pre-print server) COLCORONA study, sponsored by the Montreal Heart institute and conducted in 6 countries aimed to show if using colchicine would decrease risk of hospitalization and death in outpatients with COVID-19. Will it work? How's the study design? Learn the facts.Reference: Tardif J, Bouabdallaoui N, L'Allier P, et al. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Pre-Print. https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1CPE details for GameChangers Podcast March 2021Learning Objective: Apply the results of the CORCORONA study to patients with COVID-19 disease.0107-0000-21-097-H01-P0.25 CEU/2.5 Hrs (Knowledge)Initial Release Date: 03/02/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 22 Dec 2020 | Keep Your Poop to Yourself | GameChangers | 00:24:00 | |
Clostridioides difficile is an important cause of morbidity and mortality in the United States with over 500,000 infections annually. The Infectious Disease Society of America released a clinical quality measure focused on treatment of c diff in March 2020. A review of the diagnosis and treatment will help providers improve quality.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. | |||
| 06 Oct 2020 | Never, Never Gonna Give Ya Up | GameChangers | 00:26:32 | |
Medications are only 10 percent of total US healthcare expenditure, yet remain a focus of healthcare costs. In this Gamechangers episode, Geoff Wall and guest, Jake Galdo, will discuss two articles evaluating generic utilization on Medicare costs. By giving up brands, can we lower costs?Additional Resource/Reference: https://jamanetwork.com/journals/jamacardiology/article-abstract/2770174 and https://jamanetwork.com/journals/jama/fullarticle/2697695This episode is accredited for CPE. Subscribe at CEimpact https://www.ceimpact.com/pharmacist and claim your CE today! See omnystudio.com/listener for privacy information. | |||
| 07 Aug 2020 | New ASAM Guidelines for Ethanol Withdrawal | GameChangers | 00:23:00 | |
Ethanol use disorder continues to be a major problem in the U.S. The stress and anxiety related to the COVID-19 pandemic may exacerbate alcohol use disorder. Tune in to this episode to learn the latest in guideline updates relative to the management of ethanol withdrawal.Additional Resources/ReferencesAlcohol Withdrawal Management Guideline: https://www.asam.org/Quality-Science/quality/guideline-on-alcohol-withdrawal-managementThis episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/2OB3RDi See omnystudio.com/listener for privacy information. | |||
| 13 Apr 2021 | The Good the Bad & the Ugly | GameChangers | 00:29:24 | |
More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate.This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement.Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download CPE details for GameChangers Podcast April 2021Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates.0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 19 Jan 2021 | My Shot! | GameChangers | 00:31:02 | |
The unbelievable happened in 2020 - a vaccine was developed with high efficacy within 12 months for a novel virus! In December two vaccines for the prevention of the SARS-CoV-2 virus were approved through Emergency Use Authorization in the US. Is it time to get a shot?This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Polack F, Thomas S, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine. NEJM. Dec 10, 2020. DOI: 10.1056/NEJM2034577Baden L, El Sahly H, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. NEJM. Dec 30, 2020. DOI: 10.1056/NEHMoa2035389ACIP Recommendations: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/covid-19.html See omnystudio.com/listener for privacy information. | |||
| 26 Jun 2020 | Racism is a Public Health Emergency | GameChangers | 00:31:00 | |
Racism is a public health emergency and a root cause of social determinants of health. If we are to practice patient-centered care, and education our pharmacists to better serve their patients, we ought to act to dismantle structural racism and start by having some honest conversations. In this episode, we'll talk with Dr. Vibhuti Arya about our role as pharmacists in addressing this public health emergency.Special Guest: Vibhuti Arya, PharmDAssociate Clinical Professor, St. John's UniversityClinical Advisor, New York City Department of Health and Mental HygieneView Dr. Arya's Tedx Talk here: https://www.youtube.com/watch?v=vnYE0n7Tx_o This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/2BgRwRs Racism, SDOH, social determinants of health, anti-racist See omnystudio.com/listener for privacy information. | |||
| 09 Feb 2021 | What's the Scoop on the Poop? | GameChangers | 00:28:40 | |
Irritable bowel syndrome is a common disorder that exacts a significant toll on quality of life. For the first time, the American College of Gastroenterology has published guidelines on the diagnosis and treatment for this disorder.This episode is accredited for CPE. Subscribe at CEimpact( https://www.ceimpact.com/pharmacist ) and claim your CE today!Reference: Lacy, Brian E. PhD, MD, FACG1; Pimentel, Mark MD, FACG2; Brenner, Darren M. MD, FACG3; Chey, William D. MD, FACG4; Keefer, Laurie A. PhD5; Long, Millie D. MDMPH, FACG (GRADE Methodologist)6; Moshiree, Baha MD, MSc, FACG7 ACG Clinical Guideline: Management of Irritable Bowel Syndrome, The American Journal of Gastroenterology: January 2021 - Volume 116 - Issue 1 - p 17-44 doi: 10.14309/ajg.0000000000001036.Accessed at https://journals.lww.com/ajg/Fulltext/2021/01000/ACG_Clinical_Guideline__Management_of_Irritable.11.aspx Bristol stool scale (recommend tertiary references): Lewis, SJ; Heaton, KW (September 1997). "Stool form scale as a useful guide to intestinal transit time". Scand. J. Gastroenterol. 32 (9): 920–4. doi:10.3109/00365529709011203. PMID 9299672.CPE details for GameChangers Podcast February 2021Learning Objective: Discuss appropriate treatments for irritable bowel syndrome0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 02 Feb 2021 | That Really Ticks Me Off | GameChangers | 00:23:54 | |
Lyme disease is a complex infection and post infection syndrome can lead to serious outcomes, including death. A new guideline was developed for the diagnosis and treatment of this infection. Spoon!This episode is accredited for CPE. Subscribe at CEimpact( https://www.ceimpact.com/pharmacist ) and claim your CE today!Reference: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clinical Infectious Diseases, November 30, 2020. https://doi.org/10.1093/cid/ciaa1215. Accessed athttps://www.idsociety.org/practice-guideline/lyme-disease/ CPE details for GameChangers Podcast February 2021Learning Objective: Discuss treatment for different forms of lyme disease infections depending on the severity of symptoms0107-0000-21-XXX-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 16 Feb 2021 | Take My Breath Away | GameChangers | 00:22:12 | |
The National Asthma Education and Prevention Program released the 2020 Asthma Guideline Update in December 2020. This guideline, published in JAMA, is different from the internal Global Initative for Asthma (GINA) guidelines and represents the first update since 2007. Learn about what makes these guidelines unique and how healthcare providers can maintain breaths.This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!Reference: Commentary: Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF, Pace W, Schatz M. Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program. JAMA. 2020;324(22):2301–2317. doi:10.1001/jama.2020.21974 Guidelines: 2020 Focused Updates to the Asthma Management Guidelines. https://www.nhlbi.nih.gov/health-topics/all-publications-and-resources/2020-focused-updates-asthma-management-guidelines CPE details for GameChangers Podcast February 2021Learning Objective: Describe recommended therapy based on the staging on asthma in individuals 12 years or olderGuest Faculty: Kelli Cunningham, PharmD, BCPSDr. Cunningham reports no actual or potential conflicts of interest in relation to this episode of GameChangers.0107-0000-21-083-H01-P0.2 CEU/2.0 Hrs (Knowledge)Initial Release Date: 02/23/21Expiration Date: 02/23/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 15 Dec 2020 | Geoff Didn't Know Which Was Worse | GameChangers | 00:24:42 | |
The question of acetaminophen versus ibuprofen may finally be laid to rest. A recent meta-analysis compared the efficacy and safety of ibuprofen versus acetaminophen for the treatment of fever or pain in children younger than 2 years. Is there a drug of choice?Reference: Tan E, Braithwaite I, McKinlay CJD, Dalziel SR. Comparison of Acetaminophen (Paracetamol) With Ibuprofen for Treatment of Fever or Pain in Children Younger Than 2 Years: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(10):e2022398. doi:10.1001/jamanetworkopen.2020.22398This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today!The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. See omnystudio.com/listener for privacy information. | |||
| 24 Jul 2020 | Dexamethasone for Severe COVID Pneumonia: What Does the Data Show? | 00:27:00 | |
Overinflamation or cytokine storm is said to be the driver of acute respiratory disorder disease (ARDS) in COVID patients. A recent study conducted in the United Kingdom suggests that the steroid dexamethasone may be a weapon for prevention. In this episode, we discuss the study that caused the National Health Service in the U.K. and the CDC to change their recommendations for steroids and severe COVID.Additional Resources/ReferencesRamdomised Evaluation of COVID-19 Therapy: https://www.recoverytrial.net/ This episode is accredited for CPE. For CE details and to claim credit, click here: https://bit.ly/3h8OfTR See omnystudio.com/listener for privacy information. | |||
| 06 Apr 2021 | Don't Stop Me Now | GameChangers | 00:29:50 | |
The battle against the COVID-19 pandemic has continued for over a year. The evidence continues to update and change, and more and more people are becoming vaccinated. This episode provides a review of the newest literature including guidance on vaccinated individuals. But, remember, don't stop wearing a mask now!Reference: Interim Public Health Recommendations for Fully Vaccinated People. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html.CPE details for GameChangers Podcast April 2021Learning Objective: Describe evidence-based recommendations to mitigate SARS-CoV-2 infections0107-0000-21-158-H01-P0.2 CEU/2 Hrs (Knowledge)Initial Release Date: 04/06/21Expiration Date: 03/02/24Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. | |||
| 10 Jul 2020 | Cognitive Effects of Anticholinergics | GameChangers | 00:24:00 | |
Many patients over age 65 take daily medications that have anticholinergic properties. We know the addition of these drugs can affect quality of life and cognition. In this episode, we talk with Dr. Kristin Meyer, an expert in geriatrics to explore the latest data and discuss what Pharmacists can do to promote the appropriate use of anticholinergics.Additional Resources/ReferencesBeers Criteria:By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674-694. doi:10.1111/jgs.15767Anticholinergic Risk Scale:Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.106Recent arge study associating anticholinergics with dementia:Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study. JAMA Intern Med. 2019;179(8):1084–1093. doi:10.1001/jamainternmed.2019.0677This episode is accredited for CPE. See omnystudio.com/listener for privacy information. | |||
| 07 Feb 2022 | Annual Diabetes Update | 00:30:40 | |
Every January, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover updates from diabetes advocacy to technology changes. Learn what changed and what matters most for individuals with diabetes.
00:00 – Introductions 03:25 – Improving Care and Promoting Health 06:07 – Classification of Diabetes 07:55 – Prevention of Diabetes 10:02 – Comprehensive Medication Evaluation 12:05 – Facilitating Behavior Changes 14:14 – Glycemic Targets & DM Technology 17:08 – Obesity 18:15 – Pharmacologic Approach 24:00 – Cardiovascular Disease 25:26 – Chronic Kidney Disease Management 26:06 – Retinopathy, Neuropathy, & Foot Care 28:15 – Diabetes in Older Adults 29:38 – Closing Remarks John (Jake) A. Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Pharmacist, Ross Bridge Pharmacy CEO, Seguridad, Inc Dr. Galdo received his Doctor of Pharmacy and completed PGY-1 Community Pharmacy Residency training from the University of Georgia, earned a Master of Business Administration from Samford University, and is board certified in both pharmacotherapy and geriatrics. Jake Galdo helps lead content and course development at CEimpact. Links to Resources: Standards of Medical Care in Diabetes-2022 Take a deeper dive into glycemic management with Sue Cornell, BS, Pharm.D, CDCES, FAPhA, FADCES: CEimpact Dr. Cornell currently serves as the associate director of experiential education and professor in the department of pharmacy practice at Midwestern University College of Pharmacy in Downers Gove, Illinois. She is also a certified diabetes care and education specialist. How to Claim CE: · CME Need a membership? Continuing Education Information:
Dr. Wall is a member of the Janssen Speaker's Bureau. | |||
| 14 Feb 2022 | Semaglutide or Liraglutide for Weight Loss? | 00:18:13 | |
Weight gain can impact patient’s quality of life and put them at risk for health complications. While weight loss can be an important factor in a patient’s health, it is equally important that it is done safely and effectively. Listen in as host, Geoff Wall compares the safety and efficacy of semaglutide and liraglutide in weight loss. The GameChanger:
Show Segments: 00:00 – Introductions 01:10 – GLP-1s Agonist (Semaglutide vs Liraglutide) in Weight Management 10:00 – Change in Body Weight 12:02 – Secondary Outcomes – Blood Pressure, Blood Sugar, Lipid Concentrations, & Serum Insulin 12:59 – Safety & Side Effects 14:15 – Cost 14:52 – The GameChanger 17:20 – Closing Remarks Links to Resources: How to Claim CE: CE is available for CEimpact members: · Click here to claim CPE Credit · Click here to claim CME Credit Need a membership? Continuing Education Information: | |||
| 11 Mar 2022 | tooktake | 00:17:10 | |
Up to 69% of #Hospitalizations are caused by Medication Non-Adherence. Think of the impact pharmacists could make on the healthcare spend and patient outcomes if we could have a significant impact on that! Tooktake is a new medication reminder. This episode explores how you can offer a new, simple and inexpensive wellness tool to help your patients. It's a new medication reminder called “tooktake”. Guest For more information or access to these tools - check out the Practice Resource section of The Pharmacy Network. Read more about Leeanna's story on how she started tooktake in CEimpact's blog. The Level Up podcast is where we share tools and resources to help you 'level up' your pharmacy practice. | |||
| 21 Feb 2022 | GameChangers: A Year in Review Part 1 | 00:50:39 | |
Part 1 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers in 2021. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more. John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake) Geoff Wall, PharmD., BCPS, FCCP, CGP References and Resources Need a membership? This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE. CE Information 1. Classify "Gamechangers" by how they affect practice settings. Learning Objectives – Pharmacy Technicians 1. Classify "Gamechangers" by how they affect practice settings. 0.075 CEU/0.75 hr | |||
| 23 Feb 2022 | Precepting the Whole Student | 00:26:23 | |
It's easy to focus on the development of clinical skills in our pharmacy learners, but what is our responsibility as preceptors for their personal and professional development? Join us for this episode where Jake Galdo and Josh Kinsey share their thoughts on the importance of developing the whole student, and how this investment will positively impact pharmacy practice. We'll touch on everything from the importance of creating safe space to counseling students on the importance of personal finance. At the end of this course, preceptors will be able to: 1. Discuss the importance of supporting students in their personal and professional development 2. Describe strategies to engage students in conversations around career planning, fiscal responsibility, work-life balance, and overall well-being. UAN: 0107-0000-25-018-H99-P
| |||
| 28 Feb 2022 | GameChangers: A Year in Review Part 2 | 00:50:22 | |
Part 2 of this special two-part series takes a deep dive into the top clinical medicine and healthcare issues that have been true GameChangers this past year. Join us as Geoff Wall and Jake Galdo discuss the latest in practice trends, policy changes, guideline updates, new laws, and much more. Did you miss Part 1? If so, be sure to check out GameChangers Episode #308 for more important GameChangers! Host: Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk. Guest: Dr. Wall is a member of a speaker’s bureau for Janssen. References and Resources Already a member? Redeem your CPE or CME credit here Need a membership? This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for this year's PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE for pharmacists and pharmacy technicians. CE Information Learning Objectives – Pharmacists and Prescribers Upon successful completion of this knowledge-based CPE activity, participants should be able to:
0.075 CEU/0.75 hr Learning Objectives – Pharmacy Technicians Upon successful completion of this knowledge-based CPE activity, participants should be able to:
0.075 CEU/0.75 hr | |||
| 07 Mar 2022 | Tramadol versus Codeine: Which is Safer? | 00:22:45 | |
Opioids are always in the news for adverse reactions and poor outcomes. Two opioids - tramadol and codeine - are often left out of the fey as potential alternatives. Yet, these medications are not without adverse events. A recent study evaluated the mortality and safety differences in tramadol and codeine. Redeem your CPE or CME credit here! Need a membership? References and resources: Xie J, Strauss VY, Martinez-Laguna D, et al. Association of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes. JAMA. 2021;326(15):1504–1515. doi:10.1001/jama.2021.15255 Continuing Education Information: Learning Objectives:
Dr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 Hrs ACPE UAN: 0107-0000-22-097-H01-P Initial release date: 03/7/22 Expiration date: 03/7/2023 Additional CPE & CME details can be found here | |||
| 25 Mar 2022 | Pharmacy Isn't a Vending Machine | 00:26:04 | |
Are you still using post-it notes, clips, and stickers to facilitate your Pharmacy's workflow? You aren't alone - many of us are using tactile tools to run our pharmacies. Even if you are leveraging technology, can you confidently say you are maximizing it? We've come to the point that maximizing technology isn't a choice; it's necessary to save our profession. This episode digs into what pharmacy practice should look like - centering dispensing on the knowledge the pharmacist provides which both maximizes outcomes and ensures safe medication use. In this episode, Community Pharmacist Joe Williams shares his thoughts on the type of pharmacy practice we need to implement to save our profession. As much as technology supports practice, it doesn't remove the human element. Learn how putting the pharmacist at the center of dispensing can be done through technology. Segments you don’t want to miss: 5:30 - Pharmacies aren’t just vending machines 9:58 - The biggest mistake our profession has made…and what we need to do 12:25 - Technology – it doesn’t replace a Pharmacist – it allows us to survive This episode is sponsored by RxSafe, an innovative technology solution designed to accelerate your pharmacy’s success. Learn more about Rxsafe here. Join The Pharmacy Network to continue this conversation and check out RxSafe in the Practice Resource section! | |||
| 18 Mar 2022 | Using Adherence to Expand Care | 00:17:34 | |
Level Up: Is your pharmacy ready for the future and able to handle the present environment? | |||
| 14 Mar 2022 | New Drugs | 01:40:09 | |
Direct to consumer marketing has been a GameChanger in recent years. As new drugs are approved and marketed, healthcare teams must stay ahead of the news and advertisements in order to educate patients and peers on the risks, benefits, and nuances that impact our patients and our practice. Tune into this special, extended 90-minute episode to catch up on recent medications impacting practice.
Host: John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake) Dr. Galdo serves in an advisory role and as a member of a speaker’s bureau for Novo Nordisk.
Guest: Joe Strain Pharm.D Dr. Strain has no relevant financial relationships to disclose. References and Resources Already a member? Redeem your CPE or CME credit here! Need a membership? This episode was made possible by the PharmaCE Expo and the Iowa Pharmacy Association. Register for this year's PharmaCE Expo May 17-18 at the Hilton Des Moines Downtown here! Pharmacists and pharmacy technicians who register receive CPE for this course AND have the opportunity to receive over 14 hours of CE for pharmacists and pharmacy technicians. Learning Objectives – Pharmacists and Prescribers Upon successful completion of this knowledge-based CPE activity, participants should be able to:
0.15 CEU/1.5 hr UAN: 0107-0000-22-117-H01-P Learning Objectives – Pharmacy Technicians Upon successful completion of this knowledge-based CPE activity, participants should be able to:
0.15 CEU/1.5 hr UAN: 0107-0000-22-117-H01-T Initial release date: 03/14/2022 | |||
| 21 Mar 2022 | Exercise is a GameChanger | 00:23:32 | |
Routine exercise is gamechanging. In this epsiode, Geoff is joined by Keaton Higgins, pharmacy student and certified athletic trainer, to discuss the mortality benefits of regular exercise. Redeem your CPE or CME credit here! Need a membership? References and resources: Saint-Maurice PF, Graubard BI, Troiano RP, et al. Estimated Number of Deaths Prevented Through Increased Physical Activity Among US Adults. JAMA Intern Med. Published online January 24, 2022. doi:10.1001/jamainternmed.2021.7755 Continuing Education Information: Learning Objectives: Dr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 Hrs | |||
| 23 Mar 2022 | Failure to Fail | 00:19:25 | |
Perhaps one of the greatest challenges a preceptor has is that of honestly evaluating poor performance in a way that will help get the student either back on track, or connected to the help and support they need, depending on the specific performance issue or issues they are exhibiting. It sounds cold, but in experiential education it has been said more often than once – that sometimes you just have to fail a student for their own benefit and ultimate success. Those conversations are heartbreaking – for the preceptor, for the school’s staff – and most importantly for the students. Listen in as Dr. Lisa Richter and Dr. Kate Newman discuss the evidence and importance of failure in supporting student development. CPE Information At the end of this course, preceptors will be able to:
UAN: 0107-0000-25-019-H99-P | |||
| 28 Mar 2022 | Famotidine and Lockdowns - COVID Solutions? | 00:24:53 | |
The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19. The GameChangers Show Segments 00:00 – Introductions Host Redeem your CPE or CME credit here! Need a membership? References and resources:
Continuing Education Information: Learning Objectives:
Dr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 Hrs | |||
| 04 Apr 2022 | Dual Therapy in Depression | 00:19:30 | |
Approximately 1 in 5 individuals in the United States alone will experience depression during their lifetime. Current guidelines suggest that monotherapy may be used as initial therapy for major depressive disorder, but what evidence exists suggesting that starting dual anti-depressant therapy may have better outcomes? Join your host, Geoff Wall as he discusses a recent meta-analysis regarding dual therapy in depression.
The GameChanger: For initial therapy or patients who are non-respondent to previous treatment, dual anti-depressant therapy may have a small, but significant impact on treatment outcomes, specifically treatment efficacy.
Show Segments 00:00 – Introductions 01:19 – Dual Therapy in Depression 11:57 – Which Anti-Depressant Combination? 15:27 – The GameChanger 18:37 – Closing Remarks
Host:
References and resources:
Redeem your CPE or CME credit here! Need a membership?
Continuing Education Information: Learning Objectives:
Dr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 Hrs | |||
| 11 Apr 2022 | Switching Generics with Levothyroxine | 00:26:00 | |
Current guidelines do not recommend switching between different levothyroxine products due to concerns of potential changes in TSH levels. However, getting the same levothyroxine product every time may be difficult for patients due to financial or stocking constraints. Join your host, Geoff Wall, and guest, Dr. Jamie Pitlick to discuss a recent study that examined the consequences of switching between levothyroxine products. The GameChanger Based on a recent study, switching between different levothyroxine products may not significantly or clinically impact TSH levels in patients. Show Segments 00:00 – Introduction Host Geoff Wall, PharmD., BCPS, FCCP, CGP Guest Jamie Pitlick, PharmD, BCPS, PC-ADM References and Resources Redeem your CPE or CME credit here! Need a membership? Continuing Education Information: Learning Objectives: 1. Describe the outcomes of the study evaluating the impact of switching levothyroxine generic manufacturers 2. Discuss with patients the results of the study and clinical implications Dr. Wall is a member of the Janssen Speaker's Bureau. 0.05 CEU | 0.5 Hrs
| |||
| 18 Apr 2022 | Corticosteroids in Septic Shock | 00:20:18 | |
Septic shock is one of the most common causes of deaths in critically ill patients. The updated Surviving Sepsis Campaign Guidelines provide recommendations on the use of adjunct steroids in the treatment of sepsis. However, when to start corticosteroids is still unknown – or is it? This episode of GameChangers evaluates the timing of corticosteroid use in sepsis. The GameChanger Show Segments Host Dr. Wall is a member of the Janssen Speaker's Bureau.
Redeem your CPE or CME here! Need a membership? CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify ideal timing of corticosteroids use in septic shock patients 0.05 CEU | 0.5 Hrs | |||
| 25 Apr 2022 | Reliever Inhaled Glucocorticoid Treatment | 00:29:23 | |
Reliever Inhaled Glucocorticoid Treatment Black and Latinx patients are disproportionately impacted by asthma. In fact, asthma mortality rates are twice as high in Black patients compared to White patients. Are there different treatment options to help improve mortality in these populations? Join host Geoff Wall with guest Dr. Matt Trump as they discuss the PREPARE trial. The GameChanger Show Segments 00:00 – Introduction Host Geoff Wall, PharmD., BCPS, FCCP, CGP Guest Dr. Matt Trump, DO, FACP, FCCP Dr. Trump is a consultant for Fishter and Paykel Healthcare and an investigator for Astra Zeneca. All relevant financial relationships have been mitigated. References and Resources Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma Redeem CPE or CME Redeem CPE (Pharmacists) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the disparity of outcomes in asthma between different demographics 2. Discuss the role of reliever inhaled glucocorticoids for persons with asthma
0.05 CEU/0.5 Hr
| |||
| 02 May 2022 | The Case Where a Medical Mistake Was Criminal | 00:27:37 | |
A nurse was found guilty of gross neglect and negligent homicide in Tennessee. This case has been closely watched by medical professionals, because it may set a new precedent for criminalizing medical mistakes. Guests David Brushwood and Jake Galdo join the podcast to try and make sense of this sensational news. The GameChanger: This case may change the way in which medical mistakes are handled internally and at a legal level. Show Segments: Host: Guests: John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake) Redeem your CPE or CME credit Redeem CPE (Pharmacists) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership References and Resources: Former nurse found guilty in accidental injection death of 75-year-old patient Continuing Education Information: Learning Objectives: Drs. Brushwood and Galdo have nothing to disclose. All relevant financial relationships have been mitigated. 0.05 CEU | 0.5 Hrs | |||
| 09 May 2022 | Sodium Reduction in Heart Failure | 00:23:35 | |
A low salt diet can be difficult to maintain, especially in the United States. Multiple guidelines and decades of practice have suggested dietary limitation of sodium for patients with heart failure as an essential lifestyle modification. The recently published SODIUM-HF study evaluates this recommendation and enhances the data. The GameChanger While a 20-25% reduction in serum sodium may not improve rates of hospitalization or mortality, it may improve a patient’s quality of life. Patients should be educated on how reducing sodium in their diet may improve their symptoms and increase their quality of life. Host Geoff Wall, PharmD., BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health Show Segments 00:00 – Introductions 01:25 – SODIUM-HF Study & Sodium in Diets 20:30 – The GameChanger 22:40 – Closing Remarks Redeem your CPE or CME credit: Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership Prescribers: Get a membership References and Resources Continuing Education Information: Learning Objectives: 1. Apply the data of the SODIUM-HF study to patients with heart failure 2. Describe the strengths and weaknesses of the SODIUM-HF study 0.05 CEU | 0.5 Hrs ACPE UAN: 0107-0000-22-193-H01-P Initial release date: 05/09/22 Expiration date: 05/09/2023 Additional CPE & CME details can be found here | |||
| 16 May 2022 | Metformin, Men, and Birth Defects | 00:20:52 | |
A recent study evaluated the role of metformin in causing birth defects, but when the men are prescribed metformin. This obstetrics study evaluates the role of the partner in risk for birth defects. Does the study change practice? Listen as host Geoff Wall discusses how pregnancy involves both partners. Host All relevant financial relationships have been mitigated. References and Resources Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study Redeem your CPE or CME Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information 0.05 CEU/0.5 Hr | |||
| 23 May 2022 | STIs Part I: Candidiasis, Trichomoniasis, and Bacterial Vaginosis | 00:27:12 | |
The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything but HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice. Show Segments Host All relevant financial relationships have been mitigated. References and Resources Redeem your CPE or CME. Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) CE Information Learning Objectives
0.05 CEU/0.5 Hr | |||
| 30 May 2022 | STIs Part II: Herpes and Syphilis | 00:22:36 | |
The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything by HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice. NAAT testing is the standard of care for genital herpes, although false negatives can occur if lesions are healing. There is no difference in genital outbreaks when comparing episodic treatment and daily prophylaxis in herpes. Finally, one dose of long-acting penicillin IM has been shown to be sufficient in most patients with early syphilis. Show Segments Host All relevant financial relationships have been mitigated. References and Resources Redeem your CPE or CME Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information
0.05 CEU/0.5 Hr | |||
| 06 Jun 2022 | STIs Part III: Gonorrhea and Chlamydia | 00:30:13 | |
The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything by HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice. The GameChanger Show Segments Host All relevant financial relationships have been mitigated. References and Resources Redeem your CPE or CME Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information Learning Objectives
0.05 CEU/0.5 Hr | |||
| 13 Jun 2022 | A Primer for Gender Affirming Care | 00:24:45 | |
Transgender individuals are more likely to receive unequal care and are less likely in general to seek care or preventative services. Often, they are even relied upon to educate their own providers on the basic tenets of transgender care. Healthcare providers can better serve these patients through an interprofessional approach to comprehensive, respectful, and gender-affirming support. Listen in to this week’s episode as Dr. Anisa Hansen describes important steps we can take to have a positive impact on the health of this patient population. Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information | |||
| 20 Jun 2022 | The Role of ApoB in Cardiovascular Disease | 00:30:04 | |
Adequate risk assessment and management are crucial in preventing cardiovascular disease. A recent study examined the correlation between common measures of cholesterol concentration versus the number of apolipoprotein B (apo-B)-containing lipoproteins. In other words, should clinicians use different biomarkers for cardiovascular risk assessment? Cardiology Pharmacist, Lindsay Davis, joins Geoff Wall in this discussion. Show Segments 00:00 – Introductions
Redeem your CPE or CME credit Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Continuing Education Information: | |||
| 04 Jul 2022 | Tirzepatide: A "Twincretin" GameChanger? | 00:23:24 | |
Curious about tirzepatide and what it means for patients? Tirzepatide, a combination GLP-1 and GIP agonist, was just approved by the Food and Drug Administration for the treatment of diabetes. Tirzepatide has also gained attention for its weight-reducing effects. However, how does tirzepatide compare to other GLP-1 agonists? Is tirzepaide a GameChanger for type 2 diabetes management? Learn more with host, Geoff Wall. The GameChanger Show Segments Host References and Resources
Redeem your CPE or CME here Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
CE Information Upon successful completion of this knowledge-based activity, participants should be able to:
0.05 CEU/0.5 Hr | |||
| 01 Jun 2022 | Using Social Media to Engage Experiential Learners | 00:27:13 | |
Twitter for educational purposes? Actually, yes! Listen in to hear how Timothy Gauthier, a social media savvy pharmacist and educator, uses social media in pharmacy education and professional development, and how you and your students can use it as a lifelong learning tool. Timothy Gauthier reports he is a consultant for DoseMeRx, AntimicrobiaI Therapy, Inc., and Spectrum Mobile Health. Any relevant financial relationships have been mitigated. Get CE CPE Information At the end of this course, preceptors will be able to:
UAN: 0107-0000-22-233-H04-P Want more education on this and other precepting topics? Watch for our new course release – Number Needed to Tweet: Using Social Media to Engage Experiential Learners Check out our Preceptor Library for a full suite of timely and relevant topics for pharmacy preceptors. Finally, follow our guest, Tim Gauthier, as he continues to engage learners through his social media presence: | |||
| 31 May 2022 | Community Health Worker | 00:16:54 | |
The CDC defines a Community Health Worker (CHW) as a frontline public health worker who is a trusted member of their community and/or has a thorough understanding of the community being served. Who would be better to fill this role than the Pharmacy Support staff! Training Pharmacy Technicians and other Pharmacy Support Staff as Community Health Workers accelerates patient care and allows them to bridge community members to local resources. Registration is now open!
Not ready to sign up? Learn more about CHW in pharmacy practice Guest | |||
| 11 Jul 2022 | Updates on Oral COVID Therapy | 00:32:37 | |
Nirmatrelvir-Ritonavir continues to be recommended for outpatient treatment of COVID-19 infections, especially as cases continue to rise. However, this therapy does present clinical challenges – from drug interactions to off-label dosing and rebound COVID-19 infections, therapy is not as easy as it sounds. Listen as host Geoff Wall describes the clinical challenges and guest Jake Galdo describes the public health considerations for nirmatrelvir-ritonavir use. Show Segments 00:00 – Introductions
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
| |||
| 18 Jul 2022 | Treating Breast Cancer with Metformin | 00:22:49 | |
Several large observational studies have suggested metformin has anti-tumor effects and may be beneficial as an adjunctive treatment option for breast cancer. This hypothesis was tested by a randomized clinical trial recently published. Listen to host Geoff Wall discuss if metformin is a miracle drug. The GameChanger Metformin can alter insulin signaling which is crucial for the development of certain types of cancer cells. Thus, in various observational and pre-clinical studies, metformin has been associated with better outcomes in breast cancer, usually in patients with diabetes. A recently published RCT found no benefit of taking adjunctive metformin in patients with breast cancer and no diabetes. Show Segments 00:00 – Introductions Host Geoff Wall, PharmD, BCPS, FCCP, CGP Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial CPE (Pharmacist) Pharmacists: Get a membership Upon successful completion of this knowledge-based activity, participants should be able to:
0.05 CEU/0.5 Hr
| |||
| 25 Jul 2022 | Monkeypox 101 | 00:22:16 | |
A NON-endemic spread of monkeypox has been reported in multiple countries – a phenomenon that has never happened before. The Centers for Disease Control and Prevention and the World Health Organization are developing plans for potential outbreaks – what are the 101s on this disease for healthcare providers?
References and resources:
Redeem your CPE or CME credit Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Continuing Education Information: | |||
| 01 Aug 2022 | Calculating Kidney Function for Patients of All Races | 00:22:14 | |
Calculating an accurate renal function in patients is crucial to ensure the right dose gets to the right patient. Previous equations to estimate glomerular filtration rate depended on a race variable. However, recent data suggests this underestimates the risk of chronic kidney disease in black patients. In this episode, host Geoff Wall discusses different methods to calculate kidney function and the relationship between mortality, kidney failure, and race The GameChanger The newly proposed eGFRcr-cys equation was the most accurate in estimating the relationship of GFR to poor outcomes regardless of race. However, even with this equation, black patients were almost uniformly found to have poorer outcomes than non-black patients
Show Segments
Host
Pharmacists: Get a membership Prescribers: Get a membership
CE Information Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the equation that best estimates risk of poor outcomes in patients with chronic kidney disease regardless of race 2. List barriers to implementing cystatin-C testing in clinic laboratories
0.05 CEU/0.5 Hr UAN: 0107-0000-22-280-H01-P Initial release date: 08/01/2022 Expiration date: 08/01/2023 Additional CPE and CME details can be found here. | |||
| 08 Aug 2022 | USPSTF Recommendations of Vitamins and Minerals | 00:24:33 | |
The United States Preventative Services Task Force issued new recommendations for the use of vitamins, minerals, and multivitamins for the prevention of cardiovascular disease and cancer. This is a revision from the 2014 recommendations and is based on recent data. Host Geoff Wall will provide a review of the recommendations – and evidence on these over-the-counter products.
Host References and resources: Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) | |||
| 15 Aug 2022 | IBS Guidelines Update | 00:28:13 | |
Irritable Bowel Syndrome (IBS) is a common disorder that greatly affects quality of life. Several medications have been approved for use in IBS – both constipation (IBS-C) and diarrhea (IBS-D). The American Gastroenterological Association just released guidelines provide evidence-based recommendations for patients.
| |||
| 22 Aug 2022 | The Pharmacotherapy of Insomnia | 00:25:00 | |
Insomnia is a common medical condition treated with a variety of pharmacologic (Rx or OTC) and non-pharmacologic options. Yet, little data exist on long-term efficacy and safety on these treatment options. Join host Geoff Wall as he discusses a recent meta-analysis comparing treatments for insomnia. Host Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) | |||
| 29 Aug 2022 | Flu Vaccines in Alzheimer’s Disease | 00:30:54 | |
Vaccine distrust and misinformation is at an all-time high. One claim is that vaccines are responsible for dementias, like Alzheimer’s Disease. A recent database study may show the exact opposite. Join host, Geoff Wall, with guest, Jake Galdo, to discuss the role of vaccines and other therapies in the prevention of Alzheimer’s Disease.
Continuing Education Information: | |||
| 27 Jun 2022 | COVID-19 Vaccines for Children | 00:32:10 | |
They are finally here! COVID-19 vaccines for children as young as 6 months. The FDA’s advisory committee unanimously voted to authorize vaccines from Pfizer & BioNTech and Moderna. But now the question, which one is best? Get a membership & earn CE for GameChangers Podcast episodes
References and Resources
Continuing Education Information | |||
| 05 Sep 2022 | Statin Plus Ezetimibe In ASCVD | 00:23:01 | |
High-Intensity Statins have been the treatment of choice for ASCVD. However, the recent non-inferiority RACING study evaluates the role of combination moderate-dose statin plus ezetimibe to high-dose statin in ASCVD. Host Geoff Wall breaks down another potential GameChanger in Pharmacotherapy.
| |||
| 12 Sep 2022 | “SMART” Asthma Pharmacotherapy | 00:30:42 | |
The GINA guidelines were updated in 2021, yet providers may not have rolled out the recent changes in practice. JAMA Clinical Guidelines Synopsis highlighted the major recommendations, including SMART therapy (single maintenance and reliever therapy) with an “A” recommendation. Join host Geoff Wall as he talks about implementing new recommendations into practice with community pharmacist and patient, Jake Galdo.
Redeem your CPE or CME credit Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Continuing Education Information: | |||
| 26 Sep 2022 | A Treatment for Monkeypox? | 00:21:49 | |
Monkeypox is the newest worldwide pandemic and closely mirrors both COVID-19 and HIV pandemics. A large difference is theoretical vaccines and treatments for monkeypox already exist. In this episode of GameChangers, host Geoff Wall, evaluates tecovirimat, a potential monkeypox treatment and the regulations that made it possible. Host
Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
| |||
| 19 Sep 2022 | Pharmacogenomic Selection of Antidepressants | 00:27:37 | |
Pharmacogenomic testing has been widely available for over a decade to help guide pharmacotherapy including antidepressant selection when treating major depressive disorder. Yet, the data hasn’t substantiated improved safety or efficacy. Host Geoff Wall is joined by Sarah Grady, PharmD to evaluate the PRIME study looking at the role of pharmacogenomic testing in depression. Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Continuing Education Information: | |||
| 14 Sep 2022 | Identifying and Addressing Bias in Pharmacy Learners | 00:22:46 | |
Studies have connected racial and cultural bias in students and how they approach patient cases in their respective PharmD curriculum. How can preceptors identify and address potential bias in pharmacy learners to help ensure healthcare equity? More about Dr. LaQuoia Johnson Dr. LaQuoia Johnson is the author of How Rxacism Manifests: Inside the Small World of Pharmacy, a speaker, educator and champion for Diversity, Equity and Inclusion. Her personal mission is to create opportunities for transformational change in leadership from the lens of Grace. She is a graduate of the UNC Eshelman School of Pharmacy, Board Certified in Pharmacotherapy, and is residency trained in acute-care and pharmacy administration. Dr. Johnson spent the last decade providing patient-centered care and supporting others who do. Today, she leverages her knowledge and skills to educate the next generation of pharmacy technicians as an adjunct professor for Pharmacy Technology programs at two community colleges in North Carolina. Additionally, Dr. Johnson serves the State of North Carolina in partnership with the CDC foundation as a pharmacist consultant, and is the CEO of Growing Through It, LLC offering personal and leadership coaching and EDI-centered workshops for youth groups, corporate conferences, churches, and community-based organizations. Dr. Johnson resigned from her position in Pharmacy Leadership
CE Information At the end of this course, preceptors will be able to: 1. Discuss the possible impact implicit and explicit bias may have on students' ability to support health equity 2. Describe strategies preceptors can use help students increase their awareness of their own personal bias UAN: 0107-0000-22-321-H99-P This program has been:
Want to connect with Dr. LaQuoia Johnson? Check out her website: Want more information on this topic? If you are looking for some more specific guidance relative to implicit bias, health care disparities, and cultural competence, check out these courses: | |||
| 03 Oct 2022 | The COVID-19 Reality: An Update | 00:29:48 | |
Get FREE CE for this episode by downloading the CEimpact App (details in the FREE CE section). The current reality of COVID-19 is reviewed in this episode by Dr. Katelyn Jetelina. Dr. Jetelina is an epidemiologist and author of the wildly popular Newsletter, Your Local Epidemiologist, available via Substack. We are losing ~400 Americans a day. During the first week of September, we lost 2,299 people. In August 2022 alone, we lost 15,284 Americans to COVID-19. This means COVID-19 remains the third leading cause of death in our repertoire of threats. And it’s largely preventable[1]. Pharmacists continue to support the frontlines of the COVID-19 Pandemic. This episode shares insights on the current reality as well as what you need to know about bivalent boosters, and vaccinating children. The COVID-19 pandemic is still ‘a thing’ and the best source of protection are vaccines. The new bivalent booster vaccine provides opportunities to protect ourselves and our communities. If you, your pharmacist or technicians need Immunization Training – check out CEimpact’s VIRTUAL Administration Training. Use discount code THANKYOU to save 10%. 00:00 - Introductions 03:38 - Is COVID-19 Still a Thing? 10:55 - The GameChanger: Bivalent Booster 17:15 - The Different Boosters 19:40 - Applying to Practice: Dosing 22:48 - Pediatric Considerations 28:35 - Closing Thoughts References and Resources
Host
| |||
| 10 Oct 2022 | Restrictive versus Standard Fluids in Septic Shock | 00:25:16 | |
The current standard of care is to provide a bolus of 30 mL per kg of isotonic fluid for patients with septic shock. Recent retrospective studies question this practice. Join host, Geoff Wall, as he reviewed a NEJM article on the role of fluids in septic shock. Host Redeem your CPE or CME here Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) CE Information | |||
| 17 Oct 2022 | Acetazolamide for Diuresis in Hospitalized Heart Failure Patients | 00:26:35 | |
Studies suggest that patients admitted to the hospital with heart failure are inadequately diuresed before discharge. Join host, Geoff Wall, as he reviews the data on acetazolamide for diuresis in heart failure. 02:15 - Current Use of IV Diuretics 06:15 - Background on Acetazolamide 08:22 - The ADVOR Study 18:38 - Gamechanger: Study Results 20:32 - Connecting to Practice 25:35 - Closing Remarks
| |||
| 19 Oct 2022 | Integrating Students to Enhance Pharmacy Services | 00:40:49 | |
So often, we can fall into the trap of viewing our time with experiential learners as a burden – something that takes time and energy that we feel we don’t have in a busy practice. How can you operationalize and optimize student contribution on-site, build trust among all parties, and overcome challenges and barriers that come along with experiential learning? Tune in to find out how one busy community pharmacist engaged his students to provide an exceptional learning experience that has enhanced their pharmacy-based services and improved care for patients. Host Dr. Anthony J. Bolus has worked in community pharmacy for over 10 years since starting as a technician in 2007 in a chain store. Dr. Bolus graduated from Samford University’s McWhorter School of Pharmacy (MSOP) with a Doctor of Pharmacy degree in 2013. Upon graduation, he became a manager at a chain pharmacy in Calera, Alabama, then returned to school in 2014/2015 to complete a postgraduate year one (PGY1) community pharmacy residency with Family Medical Services (FMS), Inc. and Samford University’s MSOP. After completing the residency, Dr. Bolus was hired to be the full time clinical coordinator of FMS, Inc., a position in which he has served for over six years now. Through this position, he helps to oversee, train, and create services beyond dispensing medications at all four of the independent store locations. Dr. Bolus currently serves as a preceptor for Samford University and Auburn University pharmacy students and also in an adjunct faculty capacity at Samford. In addition, Dr. Bolus is the founder and producer of a pharmacy radio show, Healthy Dose, which he began in 2011 and ran for 10 years on Birmingham’s Smooth Jazz Radio Station FM91.1. Healthy Dose® is now a podcast available on all podcast streaming platforms.
At the end of this course, preceptors will be able to:
UAN: 0107-0000-22-373-H99-P This program has been:
Want more information on this and related topics? Check out these courses: | |||
| 24 Oct 2022 | Aspirin De-Prescribing in Patients Taking Anticoagulants | 00:20:30 | |
The role of anticoagulant therapy (warfarin) with antiplatelet therapy (aspirin) is a balance of risk versus benefit. However, reducing risk by de-prescribing is often avoided due to hypothetical efficacy reduction. Join host, Geoff Wall, as he evaluates de-prescribing aspirin in patients taking anticoagulants. 00:58 - Aspirin Use with Anticoagulants 4:02 - Overview of Schafer et al 11:50 - The Gamechanger: Study Findings 17:48 - Connecting to Practice: DOAC Use 19:52 - Closing Remarks Host
CE Information | |||
| 31 Oct 2022 | The GRADE Studies for Type 2 Diabetes | 00:34:00 | |
The GRADE studies evaluated the pharmacotherapy of diabetes after initiation of metformin – for both micro- and macrovascular outcomes. Join host, Geoff Wall, and guest Jake Galdo as they examine these studies to determine if they are GameChangers in diabetes management. 1:40 - The GRADE Studies 12:02 - Glycemic Outcomes 16:08 - Microvascular and Cardiovascular Outcomes 21:10 - The GameChanger: Selecting a Second Medication 27:18 - Connecting to Practice: Realistic Diabetes Care 33:17 - Closing Remarks
| |||
| 07 Nov 2022 | An Update on Glucagon | 00:25:50 | |
Less than ten percent of people filled a glucagon prescription after a hospitalization due to hypoglycemia. In the past few years, a slew of new glucagon products have come to market. Join host, Geoff Wall, as he discusses how to optimize glucagon therapy with diabetes expert, Jamie Pitlick. 01:54 - The Risk of Hypoglycemia 10:45 - GameChanger: New Glucagon Products 20:40 - Connecting to Practice: What Practitioners Should Know 25:11 - Closing Remarks Host
Redeem your CPE or CME here
CE Information | |||
| 14 Nov 2022 | The Role of Dapagliflozin in Heart Failure | 00:26:50 | |
Various SGLT-2s have been shown to improve cardiovascular outcomes in the presence and absence of diabetes. A recent study evaluated the effect of dapagliflozin in mildly reduced or preserved ejection fraction. Join host, Geoff Wall, as he discusses how SGLT-2s may be a real GameChanger in heart failure with expert, Troy Lynn Lewis. Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) CE Information | |||
| 21 Nov 2022 | Food Insecurity and Cardiovascular Outcomes | 00:27:27 | |
Health Equity is achieved when every person has the opportunity to attain their full health potential and no one is disadvantaged. Oftentimes, this is evaluated and addressed through resolving social determinants of health. A recent study evaluated the impact of food insecurity on cardiovascular outcomes. Join host, Geoff Wall, as he discusses how healthcare teams can address food insecurity with guest Jake Galdo.
| |||
| 28 Nov 2022 | A Review of the AGA Obesity Guidelines | 00:26:55 | |
Obesity is still at epidemic levels in the United States. More and more medications are coming to market to help with weight loss. The American Gastroenterological Association (AGA) just released guidelines for evidence-based care for persons with obesity.
| |||
| 05 Dec 2022 | Treatment of Acute Ethanol Withdrawal | 00:25:03 | |
A recent study showed that ethanol abuse is a leading cause of death in young adults in the US and that rates of alcoholism have increased. Join host Geoff Wall as he reviews the treatment of ethanol withdrawal.
| |||
| 12 Dec 2022 | Fluid Resuscitation in Pancreatitis | 00:16:31 | |
The standard of care for pancreatitis has been aggressive (liters) of intravenous fluids. New data suggests that this level of fluid resuscitation may not be needed – and possibly harmful. Join host Geoff Wall as he evaluates the role of fluids in pancreatitis treatment. Host
| |||
| 19 Dec 2022 | Perioperative Gabapentin | 00:17:44 | |
Gabapentin is often used in a multi-model pain management strategy in both peri- and post-operative setting. Little data exists looking at the adverse effects of this practice. Join host Geoff Wall, as he reviews data from a new study looking at this question.
| |||
| 26 Dec 2022 | The 2023 GOLD Guidelines | 00:23:48 | |
COPD is a common and complex disease for both inpatient and outpatient providers. GOLD guidelines provide diagnosis and treatment recommendations for COPD and were recently updated. Join host Geoff Wall as he breaks down the salient recommendations in the 2023 GOLD guidelines.
| |||
| 16 Nov 2022 | Incorporating Risk Management Principles into Your Teaching | 00:46:33 | |
Whose job is it to teach risk management principles to pharmacy learners? Sure – they have to take a law course as part of their curricular requirements, but how much does that mean to them until they are in real life situations as part of their IPPEs, APPEs, or residency? As preceptors, it’s important that we not only recognize and manage the legal risks of welcoming pharmacy learners within our pharmacy practice but also that we are prepared to teach practical concepts such as risk management in addition to developing their clinical skills. Listen to this episode where we talk with David Brushwood, a well-known expert, and educator in the practical and professional aspects of risk management and pharmacy law. Host David Brushwood graduated with degrees in pharmacy and law from the University of Kansas. He practiced both professions prior to entering academia. David retired from the University of Florida, College of Pharmacy, in 2014 where he is currently Professor Emeritus of Pharmaceutical Outcomes and Policy. In 2015, David joined the faculty at the University of Wyoming, School of Pharmacy, and he serves there as a Senior Lecturer teaching online courses in the Master of Science in Health Services Administration program. David is a pharmacy law content developer with CEimpact, where he produces educational programs for pharmacists, pharmacy technicians, and pharmacy students. David’s primary research interests are pain management policy, patient safety regulation, and pharmacist professional responsibility. Get CE CE Information At the end of this course, preceptors will be able to: 1. Describe situations where exposure to malpractice liability may occur for preceptors during experiential learning 2. Discuss techniques for teaching risk management to pharmacy learners in the experiential learning setting UAN: 0107-0000-22-422-H99-P This program has been:
Want more information on this and related topics?
| |||
| 21 Dec 2022 | Help the Hurt - Support Students and Residents Who Experience Microgressions | 00:19:20 | |
We’ve heard a lot about microaggressions in the past couple of years. A microaggression can include verbal, behavioral, or environmental aggressions that negatively communicate about race, culture, or gender. They can be intentional or unintentional but can negatively impact healthcare interactions – whether those involve students, residents, patients, or all of the above. In this episode, speaking with Anisa Hansen, a clinical pharmacist who leads diversity, equity, and inclusion initiatives for the College of Pharmacy and Health Sciences at Drake. Her passion is educating learners on topics in the areas of mental health, LGBTQ health and wellness, and equity and inclusion. Anisa has first-hand experience supporting students who have experienced microaggressions as part of their pharmacy practice experiences. Listen to learn more about how she has navigated those situations to support students. Download this social identity mapping exercise. Don’t worry – it will make sense after you listen to the episode! Host Anisa Hansen, PharmD, is a Professor of Pharmacy Practice at Drake University in Des Moines, Iowa. She has a passion for educating students on mental health, wellness, LGBTQ health, and equity and inclusion. Anisa teaches a 3-credit J-Term course focused on LGBTQ Health Issues and a first-year course exploring the portrayal of mental illness and disabilities in the media. Anisa is the mental health clinical pharmacist for Iowa Lutheran Hospital. She provides clinical service, educates sixth-year pharmacy students, and provides medication education groups in outpatient and inpatient settings. Get CE CE Information At the end of this course, preceptors will be able to: 1. Define the concept of 'microaggression' 2. Identify strategies to support students who may experience microaggressions during experiential learning
| |||
| 02 Jan 2023 | Cardiovascular Safety of ADHD Medications | 00:20:37 | |
Stimulant medications, like methylphenidate and amphetamines, have adverse cardiovascular effects, like elevated blood pressure, increasing the risk of cardiovascular events. Join host Geoff Wall as he reviews a new meta-analysis trying to quantify the risk of ADHD medications on cardiovascular outcomes.
| |||
| 18 Jan 2023 | Asking the Right Questions of Your Students and Residents | 00:42:08 | |
Sometimes teaching isn't "telling" but "asking" - asking questions that encourage students and residents to problem-solve in a stepwise manner. Listen in as we discuss a teaching strategy that builds confidence and encourages curiosity in your learners. In this month's episode, I’m speaking with Lindsay Davis of Midwestern University – Glendale, and Kevin Carrasco, a preceptor who has jumped on the Socratic Questioning bandwagon after experiencing what a difference it has made in his effectiveness as a preceptor. During our conversation – they debunked many of the assumptions often made about Socratic questioning as a teaching method and also gave some great advice on how to approach this method in a trusting and safe way for learners. Download this pocket guide, then listen in to get started! Host Kevin Carrasco, Pharm.D., MPH Dr. Davis reports that she is employed by Pfizer. All relevant financial relationships have been mitigated. Get CE CE Information At the end of this course, preceptors will be able to: 1. Define the concept of 'microaggression' 2. Identify strategies to support students who may experience microaggressions during experiential learning UAN: 0107-0000-23-058-H99-P This program has been:
Check out this free resource to guide the implementation of Socratic Questioning in your teaching. As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free!0 | |||
| 09 Jan 2023 | Diabetes Pharmacotherapy Update | 00:28:20 | |
The American Diabetes Association Standards of Care in Diabetes are a “living” guideline – the recommendations are updated throughout the year and major revisions occur in January. In this episode, guest host, Jake Galdo, is joined by Susan Cornell as they evaluate new pharmacotherapy recommendations in the ADA Standards of Care.
| |||
| 15 Feb 2023 | What Can You Learn From Your Learners? | 00:27:26 | |
As preceptors, sometimes one of the hardest things we do is give feedback. What about when we receive it? Listen to learn how to engage students in ways that result in meaningful feedback you can use to improve your teaching. You're putting in the work. Why not make it as impactful as possible for your learners? This week I’m speaking with Nick Cox – a faculty member and preceptor in an ambulatory care setting – on the topic of feedback – how to invite it, how to prepare to receive it, and what to do with it when you like it – or not. As part of our discussion, Nick refers to this book – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book, and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the Here! Host Get CE CE Information At the end of this course, preceptors will be able to: 1. List common barriers that prevent learners from providing meaningful feedback to preceptors. 2. Describe ways to create a learning environment where students feel they can safely offer feedback. UAN: 0107-0000-23-092-H99-P This program has been:
Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners. As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free!
| |||
| 15 Mar 2023 | What Do Students Say? | 00:36:01 | |
Pharmacy learners - IPPE, APPE, Residents - may not always be forthcoming with honest feedback. But they know what they appreciate (or don't) in a learning experience. As a preceptor, your approach to teaching has a huge impact on student learning. We asked two 4th year pharmacy learners to share what matters most to them in a preceptor. Their answers may surprise you! Listen in to learn what students most value in their learning experiences and gather some strategies you can use to enhance your teaching and mentor in an impactful way for your learners. Host
Get CE CE Information At the end of this course, preceptors will be able to: 1. Identify practices that pharmacy learners most value in their preceptors and why 2. Describe effective strategies to enhance learning in the pharmacy education experience you provide
UAN: 0107-0000-23-116-H99-P
This program has been:
Want more information on this and related topics? Check out the full course created by Dr. Cox on this topic: Using Feedback to Improve Your Precepting, and learn what you can do to help facilitate better feedback from your learners. This book is a great resource for building feedback skills – Thanks for the Feedback: The Science and Art of Receiving Feedback Well. I’ve read this book and there’s something in it for everyone – from a teacher, mentor, preceptor, parent, partner, or spouse. Check out the LINK! As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask you experiential program director if you are a member so that you can access it all for free! | |||
| 16 Jan 2023 | A First Treatment for Celiac Disease? | 00:22:05 | |
Celiac disease is of the most common auto-immune diseases in the world. The only current treatment is maintaining a strict gluten-free diet. Join host, Geoff Wall, as he discusses the results of a phase 2 study investigating a novel pharmacologic treatment of Celiac disease.
| |||
| 23 Jan 2023 | Zinc for the Treatment of COVID-19 | 00:22:18 | |
Results from early COVID-19 studies are still emerging. Some micronutrients, such as zinc, have been shown to decrease the severity of viral infections yet human data is sparse. Join host, Geoff Wall, as he evaluates a new study looking at the proposed benefit of zinc in COVID-19 infections.
| |||
| 30 Jan 2023 | The DCP Study: HCTZ vs Chlorthalidone | 00:22:17 | |
Hydrochlorothiazide is the go-to thiazide for hypertension control despite better data for chlorthalidone. Join host Geoff Wall as he evaluates the new randomized controlled study to determine what is the best thiazide. | |||
| 06 Feb 2023 | A Guideline Review for Osteoporosis | 00:27:45 | |
Osteoporosis may be a forgotten disease – common but rarely treated. The 2023 guidelines are not here. Join host, Geoff Wall, as he reviews the new treatment recommendations and how we can optimize pharmacotherapy for all persons with osteoporosis. | |||
| 13 Feb 2023 | Thrombolytic Use in Persons with Stroke and Direct Oral Anticoagulants | 00:27:38 | |
Patient use of any anticoagulation during an acute stroke is a contraindication for the use of thrombolytics or clot busters. Recent meta-analyses and animal studies raise the question of this contraindication. Join guest, Geoff Wall, as he examines the data on Direct Oral Anticoagulants (DOACs) and thrombolytics. | |||
| 20 Feb 2023 | Pediatric Vaccinations | 00:27:09 | |
Routine pediatric vaccines are declining and 97% of pediatric influenza deaths are in unvaccinated children. Join host Geoff Wall, with guest Jake Galdo, as they discuss what the heck is happening with pediatric vaccines and how the healthcare community can step up. | |||
| 27 Feb 2023 | The Gold Standard Loop Diuretic for HFrEF | 00:22:17 | |
Furosemide is the most prescribed loop diuretic for heart failure; however, furosemide’s pharmacokinetic parameters are less than ideal compared to other loop diuretics. Join host, Geoff Wall, as he evaluates the first randomized controlled trial comparing loop diuretics in heart failure. | |||
| 06 Mar 2023 | The 2023 ADA Diabetes Guidelines | 00:28:21 | |
Every January, the American Diabetes Association publishes the Standards of Care in Diabetes. The guidelines are a living document and change throughout the year; however, the January update is the seminal changes for the entire document. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss what’s new and great in the guidelines. | |||